Monday marks a month since the last pr. Will next week be the big week for news? Perhaps we will see a teaser today. Come on Generex! After all, they mentioned this in that pr:
"With the results from our broad and proprietary immunological screening program, which we anticipate having in June, we will have an early indication of the immunologic efficacy and safety of an Ii-Key-SARS-CoV-2 peptide vaccine before our clinical trials even start."